Charles Rhyee
Stock Analyst at TD Cowen
(4.22)
# 1,497
Out of 4,966 analysts
656
Total ratings
54.1%
Success rate
5.4%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Rated: Buy | $235 → $283 | $262.40 | +7.85% | 21 | Aug 27, 2026 | |
| CVS CVS Health | Reiterated: Buy | $110 | $94.66 | +16.21% | 60 | Aug 26, 2026 | |
| BTSG BrightSpring Health Services | Reiterated: Buy | $81 | $58.73 | +37.92% | 12 | Aug 19, 2026 | |
| EVH Evolent Health | Rated: Buy | $5 → $6 | $4.15 | +44.75% | 50 | Aug 17, 2026 | |
| CAH Cardinal Health | Rated: Buy | $275 → $280 | $234.57 | +19.37% | 40 | Aug 13, 2026 | |
| DRIO DarioHealth | Rated: Hold | $11 → $8 | $6.93 | +15.44% | 18 | Aug 12, 2026 | |
| GDRX GoodRx Holdings | Rated: Buy | $4 → $5 | $3.35 | +49.48% | 37 | Aug 11, 2026 | |
| CRL Charles River Laboratories International | Rated: Buy | $235 → $300 | $276.83 | +8.37% | 24 | Aug 10, 2026 | |
| MDLN Medline | Rated: Buy | $53 → $45 | $32.53 | +38.33% | 5 | Aug 10, 2026 | |
| COR Cencora | Reiterated: Buy | $400 | $321.57 | +24.39% | 51 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $989 → $1,006 | $880.68 | +14.23% | 51 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $8 → $12 | $13.00 | -7.69% | 21 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $23 | $17.20 | +33.72% | 16 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $197 | $169.31 | +16.35% | 21 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $6.16 | -2.60% | 59 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $23.47 | +78.95% | 10 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 | $23.48 | -2.04% | 7 | Aug 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $213 → $288 | $258.17 | +11.55% | 25 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $419 → $492 | $587.52 | -16.26% | 15 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.60 | +73.91% | 21 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $338 | $280.76 | +20.39% | 17 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $4.69 | +219.83% | 21 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $27.13 | n/a | 1 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $98.57 | n/a | 1 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $24.41 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $170 | $214.06 | n/a | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.0001 | n/a | 3 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 → $250 | $0.0001 | n/a | 6 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $9 → $1.3 | $0.0001 | n/a | 8 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $370 → $415 | $379.09 | n/a | 6 | Apr 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $360 → $395 | $418.72 | n/a | 5 | Apr 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $29 | $32.77 | n/a | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 → $80 | $66.42 | n/a | 4 | Feb 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $410 → $460 | $403.47 | n/a | 7 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $200 → $210 | $200.45 | n/a | 5 | Jun 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $29 | $32.79 | n/a | 4 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $21.76 | n/a | 1 | Feb 25, 2014 |
Veeva Systems
Aug 27, 2026
Rated: Buy
Price Target: $235 → $283
Current: $262.40
Upside: +7.85%
CVS Health
Aug 26, 2026
Reiterated: Buy
Price Target: $110
Current: $94.66
Upside: +16.21%
BrightSpring Health Services
Aug 19, 2026
Reiterated: Buy
Price Target: $81
Current: $58.73
Upside: +37.92%
Evolent Health
Aug 17, 2026
Rated: Buy
Price Target: $5 → $6
Current: $4.15
Upside: +44.75%
Cardinal Health
Aug 13, 2026
Rated: Buy
Price Target: $275 → $280
Current: $234.57
Upside: +19.37%
DarioHealth
Aug 12, 2026
Rated: Hold
Price Target: $11 → $8
Current: $6.93
Upside: +15.44%
GoodRx Holdings
Aug 11, 2026
Rated: Buy
Price Target: $4 → $5
Current: $3.35
Upside: +49.48%
Charles River Laboratories International
Aug 10, 2026
Rated: Buy
Price Target: $235 → $300
Current: $276.83
Upside: +8.37%
Medline
Aug 10, 2026
Rated: Buy
Price Target: $53 → $45
Current: $32.53
Upside: +38.33%
Cencora
Aug 9, 2026
Reiterated: Buy
Price Target: $400
Current: $321.57
Upside: +24.39%
Aug 6, 2026
Rated: Buy
Price Target: $989 → $1,006
Current: $880.68
Upside: +14.23%
Aug 5, 2026
Rated: Hold
Price Target: $8 → $12
Current: $13.00
Upside: -7.69%
Aug 4, 2026
Reiterated: Buy
Price Target: $18 → $23
Current: $17.20
Upside: +33.72%
Aug 3, 2026
Rated: Buy
Price Target: $197
Current: $169.31
Upside: +16.35%
Aug 3, 2026
Reiterated: Hold
Price Target: $6
Current: $6.16
Upside: -2.60%
Aug 3, 2026
Reiterated: Buy
Price Target: $42
Current: $23.47
Upside: +78.95%
Aug 2, 2026
Reiterated: Hold
Price Target: $23
Current: $23.48
Upside: -2.04%
Jul 29, 2026
Rated: Buy
Price Target: $213 → $288
Current: $258.17
Upside: +11.55%
Jul 23, 2026
Rated: Hold
Price Target: $419 → $492
Current: $587.52
Upside: -16.26%
May 27, 2026
Reiterated: Buy
Price Target: $8
Current: $4.60
Upside: +73.91%
May 4, 2026
Rated: Buy
Price Target: $338
Current: $280.76
Upside: +20.39%
Nov 13, 2025
Reiterated: Buy
Price Target: $15
Current: $4.69
Upside: +219.83%
Jun 11, 2025
Reiterated: Buy
Price Target: $90
Current: $27.13
Upside: n/a
Jun 5, 2025
Initiated Coverage: Buy
Price Target: $51
Current: $98.57
Upside: n/a
Sep 9, 2024
Reiterated: Buy
Price Target: n/a
Current: $24.41
Upside: n/a
Oct 30, 2023
Reiterated: Buy
Price Target: $170
Current: $214.06
Upside: n/a
Dec 12, 2022
Reiterated: Buy
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 16, 2022
Reiterated: Buy
Price Target: $2 → $250
Current: $0.0001
Upside: n/a
May 17, 2022
Reiterated: Sell
Price Target: $9 → $1.3
Current: $0.0001
Upside: n/a
Apr 16, 2021
Reiterated: Buy
Price Target: $370 → $415
Current: $379.09
Upside: n/a
Apr 14, 2021
Reiterated: Buy
Price Target: $360 → $395
Current: $418.72
Upside: n/a
Mar 29, 2021
Initiated Coverage: Hold
Price Target: $29
Current: $32.77
Upside: n/a
Feb 8, 2021
Reiterated: Buy
Price Target: $74 → $80
Current: $66.42
Upside: n/a
Feb 1, 2021
Reiterated: Hold
Price Target: $410 → $460
Current: $403.47
Upside: n/a
Jun 16, 2020
Upgraded: Buy
Price Target: $200 → $210
Current: $200.45
Upside: n/a
Oct 30, 2015
Reiterated: Hold
Price Target: $30 → $29
Current: $32.79
Upside: n/a
Feb 25, 2014
Initiated Coverage: Buy
Price Target: $42
Current: $21.76
Upside: n/a